Create an Account

Mylan, Impax Win Ruling in Doryx Generics Patent Case

May 2, 2012

Mylan Inc. (MYL) said it began selling a generic version of the antibiotic Doryx today after a judge ruled it didn't infringe a patent held by Warner Chilcott (WCRX) Plc.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00
    Register

    We’re glad to see you’re enjoying PracticalDermatology…
    but how about a more personalized experience?

    Register for free
    You are now leaving PracticalDermatology and going to a site run by another organization.

    Press cancel to remain on PracticalDermatology. Press the link below or the continue button to keep going.